Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Christophi

Showing results (101-110 of 126) with videos related to

Pageof 13
Sort By:
Cancer Letters|February 5, 2014
Glaucarubinone and gemcitabine synergistically reduce pancreatic cancer growth via down-regulation of P21-activated kinasesDannel Yeo, Nhi Huynh, John A Beutler, et al.
ANZ Journal of Surgery|April 30, 2020
Population-based analysis of treatment patterns and outcomes for pancreas cancer in VictoriaCharles H C Pilgrim, Luc Te Marvelde, Ella Stuart, et al.
Cancer Letters|November 22, 2011
P-21 activated kinase 1 knockdown inhibits β-catenin signalling and blocks colorectal cancer growthHong He, Nhi Huynh, Kevin H Liu, et al.
JOP : Journal of the Pancreas|January 12, 2013
A fast track recovery program significantly reduces hospital length of stay following uncomplicated pancreaticoduodenectomyMehrdad Nikfarjam, Laurence Weinberg, Nicholas Low, et al.
ANZ Journal of Surgery|September 5, 2012
Outcomes of patients with histologically proven acute acalculous cholecystitisMehrdad Nikfarjam, Kiran Manya, Michael A Fink, et al.
ANZ Journal of Surgery|September 19, 2012
Primary liver leiomyoma: a review of this unusual tumourMarcos Vinicius Perini, Michael Anthony Fink, David Andrew Yeo, et al.
Cancers|June 2, 2021
Captopril, a Renin-Angiotensin System Inhibitor, Attenuates Features of Tumor Invasion and Down-Regulates C-Myc Expression in a Mouse Model of Colorectal Cancer Liver MetastasisGeorgina E Riddiough, Theodora Fifis, Katrina A Walsh, et al.
BMC Cancer|November 17, 2012
Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatmentsLinh Nguyen, Theodora Fifis, Caterina Malcontenti-Wilson, et al.
ANZ Journal of Surgery|July 26, 2016
Metabolic response evaluation for colorectal liver metastases and correlation to pathologic response and tumour markersLawrence F Lau, Carmel Murone, David S Williams, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|August 21, 2013
Comparison of two syngeneic orthotopic murine models of pancreatic adenocarcinomaMehrdad Nikfarjam, Dannel Yeo, Hong He, et al.
Pageof 13

Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
Cancer Letters|February 5, 2014
Glaucarubinone and gemcitabine synergistically reduce pancreatic cancer growth via down-regulation of P21-activated kinasesDannel Yeo, Nhi Huynh, John A Beutler, et al.
ANZ Journal of Surgery|April 30, 2020
Population-based analysis of treatment patterns and outcomes for pancreas cancer in VictoriaCharles H C Pilgrim, Luc Te Marvelde, Ella Stuart, et al.
Cancer Letters|November 22, 2011
P-21 activated kinase 1 knockdown inhibits β-catenin signalling and blocks colorectal cancer growthHong He, Nhi Huynh, Kevin H Liu, et al.
JOP : Journal of the Pancreas|January 12, 2013
A fast track recovery program significantly reduces hospital length of stay following uncomplicated pancreaticoduodenectomyMehrdad Nikfarjam, Laurence Weinberg, Nicholas Low, et al.
ANZ Journal of Surgery|September 5, 2012
Outcomes of patients with histologically proven acute acalculous cholecystitisMehrdad Nikfarjam, Kiran Manya, Michael A Fink, et al.
ANZ Journal of Surgery|September 19, 2012
Primary liver leiomyoma: a review of this unusual tumourMarcos Vinicius Perini, Michael Anthony Fink, David Andrew Yeo, et al.
Cancers|June 2, 2021
Captopril, a Renin-Angiotensin System Inhibitor, Attenuates Features of Tumor Invasion and Down-Regulates C-Myc Expression in a Mouse Model of Colorectal Cancer Liver MetastasisGeorgina E Riddiough, Theodora Fifis, Katrina A Walsh, et al.
BMC Cancer|November 17, 2012
Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatmentsLinh Nguyen, Theodora Fifis, Caterina Malcontenti-Wilson, et al.
ANZ Journal of Surgery|July 26, 2016
Metabolic response evaluation for colorectal liver metastases and correlation to pathologic response and tumour markersLawrence F Lau, Carmel Murone, David S Williams, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|August 21, 2013
Comparison of two syngeneic orthotopic murine models of pancreatic adenocarcinomaMehrdad Nikfarjam, Dannel Yeo, Hong He, et al.
Pageof 13